Thomas P Miller

  • 18820 Citations
  • 57 h-Index
1978 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1979 2016

  • 18820 Citations
  • 57 h-Index
  • 164 Article
  • 2 Chapter
  • 1 Letter
Filter
Article
1991
204 Citations (Scopus)

Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer

Salmon, S. E., Dalton, W. S., Grogan, T. M., Plezia, P., Lehnert, M., Roe, D. & Miller, T. P., Jul 1 1991, In : Blood. 78, 1, p. 44-50 7 p.

Research output: Contribution to journalArticle

Verapamil
Doxorubicin
Vincristine
Dexamethasone
Multiple Drug Resistance
5 Citations (Scopus)

New biologic markers in non-Hodgkin's lymphomas

Grogan, T. M. & Miller, T. P., 1991, In : Hematology/Oncology Clinics of North America. 5, 5, p. 925-933 9 p.

Research output: Contribution to journalArticle

Tumor Biomarkers
Non-Hodgkin's Lymphoma
Lymphoma
Biomarkers
Histocompatibility Antigens
3 Citations (Scopus)

Patients with localized non-Hodgkin's lymphomas provide opportunities for future research

Miller, T. P. & Grogan, T. M., 1991, In : Oncology (Williston Park, N.Y.). 5, 8, p. 127-132 6 p.

Research output: Contribution to journalArticle

Tumor Biomarkers
Non-Hodgkin's Lymphoma
366 Citations (Scopus)

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

Miller, T. P., Grogan, T. M., Dalton, W. S., Perry, C. S., Scheper, R. J. & Salmon, S. E., 1991, In : Journal of Clinical Oncology. 9, 1, p. 17-24 8 p.

Research output: Contribution to journalArticle

P-Glycoprotein
Verapamil
Drug Resistance
Lymphoma
Drug Therapy
7 Citations (Scopus)

Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer: A southwest oncology group study

Von Hoff, D. D., Green, S., Alberts, D. S., Stock-Novack, D. L., Surwit, E. A., Miller, T. P. & Stephens, R. L., 1991, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 14, 3, p. 193-194 2 p.

Research output: Contribution to journalArticle

fludarabine phosphate
Endometrial Neoplasms
Appointments and Schedules
Leukopenia
Proxy
7 Citations (Scopus)

Prediction of outcome in diffuse large cell lymphoma by the major histocompatibility complex class II (HLA-DR, DP, DQ) and class I (HLA-a, b, c) phenotype

Rybski, J. A., Perry, C. S., Miller, T. P., Lippman, S. M., Mcgee, D. L. & Grogan, T. M., 1991, In : Leukemia and Lymphoma. 6, 1, p. 31-38 8 p.

Research output: Contribution to journalArticle

HLA-DP Antigens
Lymphoma, Large B-Cell, Diffuse
HLA-DR Antigens
Major Histocompatibility Complex
Phenotype
158 Citations (Scopus)

Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration

Pennock, G. D., Dalton, W. S., Roeske, W. R., Appleton, C. P., Mosley, K., Plezia, P., Miller, T. P. & Salmon, S. E., Jan 16 1991, In : Journal of the National Cancer Institute. 83, 2, p. 105-110 6 p.

Research output: Contribution to journalArticle

Verapamil
Chemotherapy
Poisons
Dose
Drug Therapy
1990
35 Citations (Scopus)

Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in Stages III and IV Hodgkin's disease. A Southwest Oncology Group study

Mansfield, C. M., Fabian, C., Jones, S., Van Slyck, E. J., Grozea, P., Morrison, F., Miller, T. P., Seibert, C. & Ayyangar, K., 1990, In : Cancer. 66, 11, p. 2295-2299 5 p.

Research output: Contribution to journalArticle

Lymphography
Hodgkin Disease
Abdomen
Tomography
Laparotomy
47 Citations (Scopus)

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma

Slymen, D. J., Miller, T. P., Lippman, S. M., Perry, C. S., Kerrigan, D. P., Rybski, J. A., Rangel, C. S., Richter, L. C. & Grogan, T. M., Jan 1 1990, In : Journal of Clinical Oncology. 8, 6, p. 986-993 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
HLA Antigens
Proportional Hazards Models
Disease-Free Survival
Survival
47 Citations (Scopus)

m-BACOD Treatment for intermediate- and high-grade malignant lymphomas: A Southwest Oncology Group phase II trial

Dana, B. W., Dahlberg, S., Miller, T. P., Hartsock, R. J., Balcerzak, S., Coltman, C. A., Carden, J. O., Hartley, K. & Fisher, R. I., Jan 1 1990, In : Journal of Clinical Oncology. 8, 7, p. 1155-1162 8 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Lymphoma
Bone Marrow
Doxorubicin
Cyclophosphamide
8 Citations (Scopus)

Rationale for the use of chemotherapy in non-small cell lung cancer

Miller, T. P., 1990, In : Seminars in Oncology. 17, 4 SUPPL. 7, p. 11-13 3 p.

Research output: Contribution to journalArticle

Tumor Burden
Non-Small Cell Lung Carcinoma
Drug Therapy
Neoplasms
Adenocarcinoma
32 Citations (Scopus)

Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: A Southwest Oncology Group pilot study

Taylor, C. W., Crowley, J., Williamson, S. K., Miller, T. P., Taylor, S. A., Giri, T. G. S., Stephens, R. L. & Livingston, R. B., Nov 1990, In : Journal of Clinical Oncology. 8, 11, p. 1811-1817 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Drug Therapy
Etoposide
Therapeutics
Vincristine
48 Citations (Scopus)

Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.

Lippman, S. M., Perry, C. S., Miller, T. P., Slymen, D. J., Rybski, J. A. & Grogan, T. M., May 1990, In : Modern Pathology. 3, 3, p. 361-367 7 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
T-Lymphocytes
Interleukin-2 Receptors
49 Citations (Scopus)

Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: A groupwide Southwest Oncology Group study

Miller, T. P., Dahlberg, S., Weick, J. K., Files, J. C., Eyre, H. J., Pendergrass, K. B. & Fisher, R. I., Dec 1990, In : Journal of Clinical Oncology. 8, 12, p. 1951-1958 8 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Histology
Vincristine
Doxorubicin
Cyclophosphamide
1989
9 Citations (Scopus)

Addition of verapamil to overcome drug resistance in multiple myeloma: Preliminary clinical observations in 10 patients

Trumper, L. H., Ho, A. D., Wulf, G., Hunstein, W., Dalton, W. S., Miller, T. P. & Salmon, S. E., 1989, In : Journal of Clinical Oncology. 7, 10, p. 1578-1579 2 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Vincristine
Verapamil
Multiple Myeloma
1 Citation (Scopus)

Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer - A Southwest Oncology Group study

Collins, C., Higano, C. S., Livingston, R. B., Griffin, B. R., Keppen, M. D. & Miller, T. P., Aug 1989, In : Cancer Chemotherapy and Pharmacology. 24, 2, p. 128-132 5 p.

Research output: Contribution to journalArticle

Oncology
Chemotherapy
Small Cell Lung Carcinoma
Radiotherapy
Vincristine
508 Citations (Scopus)

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy

Dalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G. M., Taylor, C. W., Miller, T. P. & Salmon, S. E., 1989, In : Journal of Clinical Oncology. 7, 4, p. 415-424 10 p.

Research output: Contribution to journalArticle

P-Glycoprotein
Verapamil
Multiple Myeloma
Drug Resistance
Non-Hodgkin's Lymphoma
96 Citations (Scopus)
Adjuvant Radiotherapy
Lymphoma, Large B-Cell, Diffuse
Drug Therapy
Survival
Recurrence
178 Citations (Scopus)

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by p-glycoprotein staining

Salmon, S. E., Grogan, T. M., Miller, T. P., Scheper, R. & Dalton, W. S., May 3 1989, In : Journal of the National Cancer Institute. 81, 9, p. 696-701 6 p.

Research output: Contribution to journalArticle

Glycoproteins
Glycoprotein
Breast Cancer
Doxorubicin
Tumors
1988
73 Citations (Scopus)

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

Miller, T. P., Lippman, S. M., Perry, C. S., Slymen, D. J. & Grogan, T. M., 1988, In : Journal of Clinical Investigation. 82, 1, p. 370-372 3 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
HLA-DR Antigens
Phenotype
Non-Hodgkin's Lymphoma
HLA-D Antigens
183 Citations (Scopus)

Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67

Grogan, T. M., Lippman, S. M., Perry, C. S., Slymen, D. J., Rybski, J. A., Rangel, C. S., Richter, L. C. & Miller, T. P., 1988, In : Blood. 71, 4, p. 1157-1160 4 p.

Research output: Contribution to journalArticle

Nuclear Antigens
Lymphoma, Large B-Cell, Diffuse
Monoclonal Antibodies
Antigens
Cell proliferation
23 Citations (Scopus)

Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival

Perry, C. S., Lippman, S. M., Miller, T. P. & Grogan, T. M., 1988, In : Cancer. 61, 3, p. 517-524 8 p.

Research output: Contribution to journalArticle

Lymphoma
Phenotype
Survival
T-Lymphocytes
B-Lymphocytes
5 Citations (Scopus)
Virus Diseases
Lymphocyte Activation
Lymphoma
Acquired Immunodeficiency Syndrome
HIV
36 Citations (Scopus)

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Miller, T. P., Dana, B. W., Weick, J. K., Jones, S. E., Coltman, C. A., Dahlberg, S. & Fisher, R. I., Apr 1988, In : Seminars in Hematology. 25, 2 Suppl 2, p. 17-22 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Doxorubicin
Vincristine
Methotrexate
Cyclophosphamide
38 Citations (Scopus)

The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma

Perry, C. S., Grogan, T. M., Lippman, S. M., Slymen, D. J., Rybski, J. A. & Miller, T. P., 1988, In : American Journal of Pathology. 133, 1, p. 118-126 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Immunoglobulins
B-Lymphocytes
Survival
HLA-DR Antigens
113 Citations (Scopus)

The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype

Lippman, S. M., Miller, T. P., Perry, C. S., Slymen, D. J. & Grogan, T. M., 1988, In : Blood. 72, 2, p. 436-441 6 p.

Research output: Contribution to journalArticle

T-cells
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Cells
T-Lymphocytes

The reply

Grogan, T. M., Lippman, S. & Miller, T. P., 1988, In : American Journal of Medicine. 84, 1, p. 182-183 2 p.

Research output: Contribution to journalArticle

1987
16 Citations (Scopus)

Mitotic counts in follicular lymphomas

Ellison, D. J., Nathwani, B. N., Metter, G. E., Turner, R. R., Burke, J. S., Miller, T. P., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Winberg, C. D. & Whitcomb, C. C., 1987, In : Human Pathology. 18, 5, p. 502-505 4 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Non-Hodgkin's Lymphoma
Normal Distribution
Multivariate Analysis
Survival
45 Citations (Scopus)

Post-transplantation T cell lymphoblastic lymphoma

Lippman, S. M., Grogan, T. M., Carry, P., Ogden, D. A. & Miller, T. P., 1987, In : American Journal of Medicine. 82, 4, p. 814-816 3 p.

Research output: Contribution to journalArticle

T-Cell Lymphoma
B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Lymphoma
Transplantation
53 Citations (Scopus)

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure

Fox, K. A., Lippman, S. M., Cassady, J. R., Heusinkveld, R. S. & Miller, T. P., 1987, In : Journal of Clinical Oncology. 5, 1, p. 38-45 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiotherapy
Drug Therapy
Combination Drug Therapy
Lung
47 Citations (Scopus)

Salvage therapy of advanced hodgkin's disease. Critical appraisal of curative potential

Buzaid, A. C., Lippman, S. M. & Miller, T. P., 1987, In : American Journal of Medicine. 83, 3, p. 523-532 10 p.

Research output: Contribution to journalArticle

Salvage Therapy
Hodgkin Disease
Drug Therapy
Procarbazine
Mechlorethamine
51 Citations (Scopus)

Southwest oncology group clinical trials for intermediate-and high-grade non-hodgkin's lymphomas

Fisher, R. I., Miller, T. P., Dana, B. W., Jones, S. E., Dahlberg, S. & Coltman, C. A., Apr 1987, In : Seminars in Hematology. 24, 2 SUPPL. 1, p. 21-25 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Clinical Trials
Methotrexate
Vincristine
Doxorubicin
1986
2 Citations (Scopus)

A phase II study of bisantrene in malignant lymphomas - A southwest oncology group study

Miller, T. P., Cowan, J. D., Neilan, B. A. & Jones, S. E., Jan 1986, In : Cancer Chemotherapy and Pharmacology. 16, 1, p. 67-69 3 p.

Research output: Contribution to journalArticle

bisantrene
Histology
Oncology
Lymphoma
Non-Hodgkin's Lymphoma
314 Citations (Scopus)

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience

Dixon, D. O., Neilan, B., Jones, S. E., Lipschitz, D. A., Miller, T. P., Grozea, P. N. & Wilson, H. E., 1986, In : Journal of Clinical Oncology. 4, 3, p. 295-305 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Therapeutics
Age Groups
Levamisole
Survival
40 Citations (Scopus)

Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A southwest oncology group study

Miller, T. P., Chen, T. T., Coltman, C. A., O'Bryan, R. M., Vance, R. B., Weiss, G. B., Fletcher, W. S., Stephens, R. L. & Livingston, R. B., 1986, In : Journal of Clinical Oncology. 4, 4, p. 502-508 7 p.

Research output: Contribution to journalArticle

Combination Drug Therapy
Survival
Mitomycin
Vincristine
Therapeutics
22 Citations (Scopus)

Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): A Southwest Oncology Group Study

Miller, T. P., Vance, R. B., Ahmann, F. R. & Rodney, S. R., 1986, In : Cancer Treatment Reports. 70, 9, p. 1101-1104 4 p.

Research output: Contribution to journalArticle

Vindesine
Mitomycin
Non-Small Cell Lung Carcinoma
Cisplatin
Vinca
20 Citations (Scopus)

Immunologic complexity of lymphoblastic lymphoma

Grogan, T., Perry, C. S., Wirt, D. P., Hicks, M. J., Paquin, M., Hutter, J., Miller, T. P., Rangel, C., Richter, L. & Jones, S., 1986, In : Diagnostic Immunology. 4, 2, p. 81-88 8 p.

Research output: Contribution to journalArticle

B-Lymphocyte Differentiation Antigens
T Lymphocyte Differentiation Antigens
T-cells
DNA Nucleotidylexotransferase
Surface Antigens

Immunotyping malignant lymphomas. A boon to diagnosis.

Grogan, T. M., Perry, C. S. & Miller, T. P., Sep 1986, In : Cleveland Clinic Quarterly. 53, 3, p. 315-317 3 p.

Research output: Contribution to journalArticle

Immunologic Techniques
Lymphoma
11 Citations (Scopus)

Leukocyte concentrations in discrimination of benign from malignant lung lesions

Thomson, S. P., Kessler, J. F. & Miller, T. P., 1986, In : American Journal of Medicine. 80, 6, p. 1035-1040 6 p.

Research output: Contribution to journalArticle

Leukocytes
Lung
Granulocytes
Lung Neoplasms
Lymphocyte Count
6 Citations (Scopus)

Phase II trial of esorubicin (4′ deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma

Braich, T. A., Salmon, S. E., Robertone, A., Alberts, D. S., Jones, S. E., Miller, T. P. & Garewal, H. S., Sep 1986, In : Investigational New Drugs. 4, 3, p. 269-274 6 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Melanoma
Breast Neoplasms
Kidney
Lung
55 Citations (Scopus)

What should be the morphologic criteria for the subdivision of follicular lymphomas?

Nathwani, B. N., Metter, G. E., Miller, T. P., Burke, J. S., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Dixon, D. O., Winberg, C. D. & Whitcomb, C. C., 1986, In : Blood. 68, 4, p. 837-845 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Pathology
Survival
Cells
Cell Count
1985
4 Citations (Scopus)

Chemohormonal therapy for advanced breast cancer with tamoxifen, adriamycin, and cyclophosphamide (TAC)

Ahmann, F. R., Jones, S. E., Moon, T. E., Hammond, N., Miller, T. P. & Durie, B. G., 1985, In : Cancer. 56, 4, p. 730-737 8 p.

Research output: Contribution to journalArticle

Tamoxifen
Doxorubicin
Cyclophosphamide
Breast Neoplasms
Estrogen Receptors
54 Citations (Scopus)

Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: A southwest oncology group study

Jones, S. E., Grozea, P. N., Miller, T. P., Van Slyck, E. J., Balcerzak, S. P., Costanzi, J. J., Morrison, F. S., Eyre, H. J., Fabian, C. J. & Dabich, L., 1985, In : Journal of Clinical Oncology. 3, 10, p. 1318-1324 7 p.

Research output: Contribution to journalArticle

Levamisole
Vincristine
Mycobacterium bovis
Prednisone
Doxorubicin
12 Citations (Scopus)

Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow

Kronland, R., Grogan, T., Perry, C. S., Wirt, D., Rangel, C., Richter, L., Durie, B., Greenberg, B., Miller, T. P. & Jones, S., 1985, In : Human Pathology. 16, 12, p. 1247-1254 8 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Plasma Cells
Bone Marrow
Lymphocytes
B-Cell Antigen Receptors
97 Citations (Scopus)

Morphological subclassification of follicular lymphoma: Variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies

Metter, G. E., Nathwani, B. N., Burke, J. S., Winberg, C. D., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Whitcomb, C. C., Dixon, D. O. & Miller, T. P., 1985, In : Journal of Clinical Oncology. 3, 1, p. 25-38 14 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Lymphoma
Pathology
Cell Count
Clinical Studies
119 Citations (Scopus)

Peripheral T-cell lymphoma: Aggressive disease with heterogeneous immunotypes

Grogan, T. M., Fielder, K., Rangel, C., Jolley, C. J., Wirt, D. P., Hicks, M. J., Miller, T. P., Brooks, R., Greenberg, B. & Jones, S., 1985, In : American Journal of Clinical Pathology. 83, 3, p. 279-288 10 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Viral Tumor Antigens
Phenotype
Mycosis Fungoides
Lymphoma, Large B-Cell, Diffuse
3 Citations (Scopus)
Mitomycin
Vincristine
Fluorouracil
Lung Neoplasms
Combination Drug Therapy

Phase II trial of bisantrene in non-small cell lung cancer

Miller, T. P., Ahmann, F. R., Mackel, C., Greenberg, B. R. & Alberts, D. S., Dec 1985, In : Investigational New Drugs. 3, 4, p. 393-395 3 p.

Research output: Contribution to journalArticle

bisantrene
Non-Small Cell Lung Carcinoma
Appointments and Schedules
Leukopenia
1984
6 Citations (Scopus)

Chemotherapy of advanced non-small cell lung cancer - A review

Takasugi, B. J. & Miller, T. P., Sep 1984, In : Investigational New Drugs. 2, 3, p. 339-347 9 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Vindesine
Vinblastine
Non-Small Cell Lung Carcinoma
Antineoplastic Agents
29 Citations (Scopus)

Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay

Ludwig, R., Alberts, D. S., Miller, T. P. & Salmon, S. E., Apr 1984, In : Cancer Chemotherapy and Pharmacology. 12, 3, p. 135-141 7 p.

Research output: Contribution to journalArticle

Drug Evaluation
Tumors
Assays
Appointments and Schedules
Vinblastine